Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase

Human Molecular Genetics

Volumn 5, Issue 9, 1996, Pages 1311-1318

  Koshy, Beena ^c   Matilla, Toni ^c   Burright, Eric N ^a   Merry, Diane E ^b   Fischbeck, Kenneth H ^b   Orr, Harry T ^a   Zoghbi, Huda Y ^c  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; GENE PRODUCT; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; TRINUCLEOTIDE;

ARTICLE; CONTROLLED STUDY; DEGENERATIVE DISEASE; HUMAN; HUMAN CELL; MUSCLE ATROPHY; PRIORITY JOURNAL; SPINOCEREBELLAR DEGENERATION;

ANIMALS; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; MICE; MUSCULAR ATROPHY, SPINAL; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; RECEPTORS, ANDROGEN; REPETITIVE SEQUENCES, NUCLEIC ACID; SPINOCEREBELLAR DEGENERATIONS;

ATAXIA;

EID: 0029833062     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/5.9.1311     Document Type: Article

References (42)

1. Willems, P.J. (1994) Dynamic mutations hit double figures. Nature Genet., 8, 213-215, news & views.
2. Housman, D. (1995) Gain of glutamines, gain of function? Nature Genet., 10, 3-4, news & views.
3. Servadio, A., Koshy, B., Armstrong, D., Antalfty, B., Orr, H.T. and Zoghbi, H.Y. (1995) Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals. Nature Genet., 10, 94-98.
4. Chung, M.-Y., Ranum, L.P.W., Duvick, L.A., Servadio, A., Zoghbi, H.Y. and Orr, H.T. (1993) Evidence for a possible mechanism predisposing to intergenerational CAG repeat instability in spinocerebellar ataxia type 1. Nature Genet., 5, 254-258.
5. Quan, F., Janas, J. and Popovich, B.W. (1995) A novel CAG repeat configuration in the SCA1 gene: implications for the molecular diagnostics of spinocerebellar ataxia type 1. Hum. Mol. Genet., 4, 2411-2413.
6. Gusella, J.F., Tanzi, R.E., Bader, P.I., Phelan, M.C., Stevenson, R., Hayden, M.R., Hofman, K.J., Faryniarz, A.G. and Gibbons, K. (1985) Deletion of Huntington's disease-linked G8 (D4S10) locus in Wolf-Hirschhorn syndrome. Nature, 318, 75-78.
7. Quigley, C.A., Friedman, K.J., Johnson, A., Lafreniere, R.G., Silverman, L.M., Lubahn, D.B., Brown, T.R., Wilson, E.M., Willard, H.F. and French, F.S. (1992) Complete deletion of the androgen receptor gene: definition of the null phenotype of the androgen insensitivity syndrome and determination of carrier status. J. Clin. Endocrinol. Metab., 74, 927-933.
8. Trifiro, M., Gottlieb, B., Pinsky, L., Kaufman, M., Prior, L., Belsham, D.D., Wrogemann, K., Brown, C.J., Willard, H.F., Trapman, J., Brinkmann, A.O., Chang, C., Liao, S., Sergovich, F. and Jung, J. (1991) The 56/58 kDa androgen-binding protein in male genital skin fibroblasts with a deleted androgen receptor gene. Mol. Cell. Endocrinol., 75, 37-47.
9. Nasir, J., Floresco, S.B., O'Kusky, J.R., Diewert, V.M., Richman, J.M., Zeisler, J., Borowski, A., Marth, J.D., Phillips, A.C. and Hayden, M.R. (1995) Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell, 81, 811-823.
10. Zeitlin, S., Liu, J.-P., Chapman, D.L., Papaioannou, V.E. and Efstratiadis, A. (1995) Increased apoptosis and early embryonic lethality in mice nullizygous for the Huntington's disease gene homologue. Nature Genet., 11, 155-163.
11. Duyao, M.P., Auerbach, A.B., Ryan, A., Persichetti, F., Barnes, G.T., McNeil, S.M., Ge, P., Vonsattel, J.-P., Gusella, J.F., Joyner, A.L. and MacDonald, M.E. (1995) Inactivation of the mouse Huntington's disease gene homolog Hdh. Nature, 269, 407-410.
12. Burright, E.N., Clark, H.B., Servadio, A., Matilla, T., Feddersen, R.M., Yunis, W.S., Duvick, L.A., Zoghbi, H.Y. and Orr, H.T. (1995) SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat. Cell, 82, 937-948.
13. Fields, S. and Song, O.-K. (1989) A novel genetic system to detect protein-protein interactions. Nature, 340, 245-246.
14. Durfee, T., Becherer, K., Chen, P.-L., Yeh, S.-H., Yang, Y., Kilburn, A.E., Lee, W.-H. and Elledge, S.J. (1993) The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev., 7, 555-569.
15. Harper, J.W., Adami, G.R., Wei, N., Keyomarsi, K. and Elledge, S.J. (1993) The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell, 75, 805-816.
16. Ercolani, L., Florence, B., Denaro, M. and Alexander, M. (1988) Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate denydrogenase gene. J. Biol. Chem., 263, 15335-15341.
17. Harris, J.I. and Waters, M. (1976) In Boyer, P.D. (ed.), The Enzymes. Academic Press, Boca Raton, Vol. 13, pp. 1-49.
18. Brodie, A.E. and Reed, D.J. (1987) Reversible oxidation of glyceraldehyde 3 phosphate dehydrogenase thiols in human lung carcinoma cells by hydrogen peroxide. Biochem. Biophys. Res. Comm., 148, 120-125.
19. Burke, J.R., Enghild, J.J., Martin, M.E., Jou, Y.-S., Myers, R.M., Roses, A.D., Vance, J.M. and Strittmatter, W.J. (1996) Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH. Nature Med., 2, 347-350.
20. Fox, J.B. and Dandliker, W.B. (1956) A study of some of the physical properties of glyceraldehyde-3-phosphate dehydrogenase. J. Biol. Chem., 218, 53-57.
21. Harris, J.I. and Perham, R.N. (1963) Studies on glyceraldehyde 3-phosphate dehydrogenases. Biochem. J., 89, 60-64.
22. Huitorel, P. and Pantoloni, D. (1985) Bundling of microtubules by glyceraldehyde-3-phosphate dehydrogenase and its modulation by ATP. Eur. J. Biochem., 150, 265-269.
23. Singh, R. and Green, M.R. (1993) Sequence-specific binding of transfer RNA by glyceraldehyde-3-phosphate dehydrogenase. Science, 259, 365-368.
24. Schulze, H., Schuler, A., Stuber, D., Dabeli, H., Langen, H. and Huber, G. (1993) Rat brain glyceraldehyde 3-phosphate dehydrogenase interacts with the recombinant cytoplasmatic domain of Alzheimer's -amyloid precursor protein. J. Neurochem., 60, 1915-1922.
25. Seipp, S. and Buselmaier, W. (1994) Isolation of glyceraldehyde 3-phosphate dehydrogenase (Gapdh) cDNA from the distal half of mouse chromosome 16: further indication of a link between Alzheimer's disease and glycolysis. Neurosci. Lett., 182, 91-94.
26. Meyer-Siegler, K., Mauro, D.J., Seal, G., Wurzer, J., DeRiel, J.K. and Sirover, M.A. (1991) A human nuclear uracil DNA glycosylase is the 37-kDa subunit of glyceraldehyde-3-phosphate dehydrogenase. Proc. Natl Acad. Sci. USA, 88, 8460-8464.
27. Ronai, Z. (1993) Glycolytic enzymes as DNA binding proteins. Int. J. Biochem., 25, 1073-1076.
28. Kawamoto, R.M. and Caswell, A.H. (1986) Autophosphorylation of glyceraldehyde phosphate dehydrogenase and phosphorylation of protein from skeletal muscle microsomes. Biochemistry, 25, 657-661.
29. Hodor, P. and Heltianu, C. (1989) Immunocytochemical localization of glyceraldehyde-3-phosphate dehydrogenase in cultured endothelial and smooth muscle cells. Microcirc. Endothelium, & Lymphatics, 5, 485-503.
30. Morgenegg, G., Winkler, G.C., Hubscher, U., Heizmann, C.W., Mous, J. and Kuenzle, C.C. (1986) Glyceraldehyde-3-phosphate dehydrogenase is a nonhistone protein and a possible activator of transcription in neurons. J. Neurochem., 47, 54-62.
31. Rossman, M., Liljas, A., Branden, C. and Banaszak, L. (1975) In Boyer, P.D. (ed.), The Enzymes. Academic Press, Orlando, Vol. 11, pp. 61-102.
32. Constantinides, S.M. and Deal, W.C.J. (1969) Reversible dissociation of tetrameric rabbit muscle glyceraldehyde 3-phosphate dehydrogenase into dimers or monomers by adenosine triphosphate. J. Biol. Chem., 244, 5695-56702.
33. Wullner, U., Young, A.B., Penney, J.B. and Beal, M.F. (1994) 3-Nitropropionic acid toxicity in the striatum. J. Neurochem., 63, 1772-1781.
34. Brouillet, E., Hantraye, P., Ferrante, R.J., Dolan, R., Leroy-Willig, A., Kowall, N.W. and Beal, M.F. (1995) Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc. Natl Acad. Sci. USA, 92, 7105-7109.
35. Uitti, R.J., Rajput, A.M., Ashenhurst, E.M. and Rozdilsky, B. (1985) Cyanide-induced parkinsonism: a clinicopathologic report. Neurology, 35, 921-925.
36. Xiao-J., L., Shi-h, L., Sharp, A.H., Nucifora, F.C., Schilling, G., Lanahan, A., Worley, P., Snyder, S.H. and Ross, C.A. (1995) A huntingtin-associated protein enriched in brain with implications for pathology. Nature, 378, 398-402.
37. Feilotter, H.E., Hannon, G.J., Ruddell, C.J. and Beach, D. (1994) Construction of an improved host strain for two hybrid screening. Nucleic Acids Res., 22, 1502-1503.
38. Schiestl, R.H. and Gietz, R.D. (1989) High efficiency transformation of intact yeast cells using single stranded nucleic acids as a carrier. Curr. Genet., 16, 339-346.
39. Breeden, L. and Nasmyth, K. (1985) Regulation of the yeast HO gene. Cold Spring Harbor Symp. Quant. Biol., 50, 643-650.
40. Bingham, P.M., Scott, M.O., Wang, S., McPhaul, M.J., Wilson, E.M., Garbern, J.Y., Merry, D.E. and Fischbeck, K.H. (1995) Stability of an expanded trinucleotide repeat in the androgen receptor gene in trangenic mice. Nature Genet., 9, 191-196.
41. Zegers, N.D., Claasen, E., Neelen, C., Mulder, E., can Laar, J.H., Voorhorst, M.M., Berrevoets, C.A., Brinkmann, A.O., van der Kwast, T.H., Ruizeveld de Winter, J.A., Trapman, J. and Boersma, W.J.A. (1991) Epitope prediction and confirmation for the human androgen receptor: generation of monoclonal antibodies for multiassay performance following the synthetic peptide strategy. Biochim. Biophys. Acta, 1073, 23.
42. Rose, M. and Botstein, D. (1983) Construction and use of gene fusions to lacZ(β-galactosidase) that are expresssed in yeast. Methods Enzymol., 101, 167-180